This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Dec;2(12):723.

doi: 10.1016/s1474-4422(03)00593-3.

Alzheimer's disease: the glycosaminoglycan sink

Chiara Briani¹, Annachiara Cagnin, Gilberto Pizzolato

Affiliations

PMID: 14636775
DOI: 10.1016/s1474-4422(03)00593-3

Comment

Alzheimer's disease: the glycosaminoglycan sink

Chiara Briani et al. Lancet Neurol. 2003 Dec.

. 2003 Dec;2(12):723.

doi: 10.1016/s1474-4422(03)00593-3.

Authors

Chiara Briani¹, Annachiara Cagnin, Gilberto Pizzolato

Affiliation

¹ Department of Neurosciences, University of Padova, Italy. chiara.briani@unipd.it

PMID: 14636775
DOI: 10.1016/s1474-4422(03)00593-3

No abstract available

PubMed Disclaimer

Comment on

Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
van Horssen J, Wesseling P, van den Heuvel LP, de Waal RM, Verbeek MM. van Horssen J, et al. Lancet Neurol. 2003 Aug;2(8):482-92. doi: 10.1016/s1474-4422(03)00484-8. Lancet Neurol. 2003. PMID: 12878436 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information